Loic Vasseur

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

Journal: Blood cancer journal

Published: March 10, 2026

CEBP and ZEB2 alterations define three distinct subtypes of B-cell acute lymphoblastic leukemia.

CEBP and ZEB2 alterations define three distinct subtypes of B-cell acute lymphoblastic leukemia.

Journal: HemaSphere

Published: February 01, 2026

Transplant versus no transplant outcome in adolescents and adults with sickle cell disease eligible for allogeneic hematopoietic stem cell transplantation.

Transplant versus no transplant outcome in adolescents and adults with sickle cell disease eligible for allogeneic hematopoietic stem cell transplantation.

Journal: HemaSphere

Published: January 10, 2026

Genomic landscape of acute myeloid leukemia in adolescents and young adults.

Genomic landscape of acute myeloid leukemia in adolescents and young adults.

Journal: Leukemia

Published: December 11, 2025

Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC.

Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC.

Journal: Bone marrow transplantation

Published: November 08, 2025

Challenges in handling allogeneic stem cell transplantation in randomized clinical trials.

Challenges in handling allogeneic stem cell transplantation in randomized clinical trials.

Journal: Journal of clinical epidemiology

Published: October 21, 2025

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Journal: Leukemia

Published: August 25, 2025

Blinatumomab in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in complete remission with positive minimal residual disease

Blinatumomab in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in complete remission with positive minimal residual disease

Journal: Bulletin du cancer

Published: July 21, 2025

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

Journal: European journal of haematology

Published: March 27, 2025

Real-world outcomes of haplo-HSCT with post-transplant cyclophosphamide in pediatric hematologic malignancies: a study on behalf of SFGM-TC and SFCE.

Real-world outcomes of haplo-HSCT with post-transplant cyclophosphamide in pediatric hematologic malignancies: a study on behalf of SFGM-TC and SFCE.

Journal: Bone marrow transplantation

Published: December 20, 2024

Update on long-term outcomes of a cohort of patients with TCF3::HLF-positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation.

Update on long-term outcomes of a cohort of patients with TCF3::HLF-positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation.

Journal: Haematologica

Published: November 09, 2024

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.

Journal: Blood

Published: September 09, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026